MassMutual Private Wealth & Trust FSB Acquires 137 Shares of Encompass Health Co. (NYSE:EHC)

MassMutual Private Wealth & Trust FSB grew its stake in shares of Encompass Health Co. (NYSE:EHC) by 87.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 293 shares of the company’s stock after buying an additional 137 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in Encompass Health were worth $27,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. UMB Bank n.a. lifted its stake in Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after buying an additional 252 shares during the period. V Square Quantitative Management LLC lifted its stake in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares in the last quarter. Avior Wealth Management LLC bought a new position in shares of Encompass Health in the third quarter worth $40,000. Benjamin F. Edwards & Company Inc. lifted its position in Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after buying an additional 198 shares during the last quarter. Finally, Tompkins Financial Corp bought a new stake in Encompass Health in the fourth quarter valued at approximately $46,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the topic of a number of recent research reports. Truist Financial restated a “buy” rating and issued a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Barclays lifted their price target on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. KeyCorp raised their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, Royal Bank of Canada boosted their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Nine research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Trading Up 0.4 %

Shares of NYSE:EHC opened at $95.65 on Friday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a market capitalization of $9.64 billion, a P/E ratio of 23.10, a P/E/G ratio of 1.13 and a beta of 0.89. The business’s 50-day moving average is $96.74 and its 200 day moving average is $94.35. Encompass Health Co. has a 1 year low of $69.95 and a 1 year high of $104.55.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.86 EPS. On average, research analysts predict that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.